Onjective Pet Student Book: 430 Libros PPS
分子显像
Tipo: Presentación Powerpoint
PET studies in cancer ... Iressa a quinazoline-based small molecule, an EGFR TK inhibitor; In phase I objective responses observed in NSCLC ... Using Biomarkers and Surrogate Endpoints to Accelerate Drug ....
https://www.alz.org/media/Documents/ww-adni-july-2015-china-update-05.ppt
-
Tipo: Presentación Powerpoint
Image DICOM Display Update: Color Presentation States Hanging ...
Tipo: Presentación Powerpoint
PET studies in cancer ... Iressa a quinazoline-based small molecule, an EGFR TK inhibitor; In phase I objective responses observed in NSCLC ... Using Biomarkers and Surrogate Endpoints to Accelerate Drug ....
https://dicom.nema.org/dicom/spie2005/WG-11_Progress.ppt
Slide 0
Tipo: Presentación Powerpoint
PET studies in cancer ... Iressa a quinazoline-based small molecule, an EGFR TK inhibitor; In phase I objective responses observed in NSCLC ... Using Biomarkers and Surrogate Endpoints to Accelerate Drug ....
https://www.alz.org/media/Documents/ww-adni-july-2016-watsubo-12.ppt
Slide 1
Tipo: Presentación Powerpoint
PET studies in cancer ... Iressa a quinazoline-based small molecule, an EGFR TK inhibitor; In phase I objective responses observed in NSCLC ... Using Biomarkers and Surrogate Endpoints to Accelerate Drug ....
https://medicine.musc.edu/-/sm/medicine/departments/surgery/pdf/education/medical-student/3rd/web-based-alternate-cases/alteredbowelfunctioncolonca.ashx
Representing Type Systems for PCC
Tipo: Presentación Powerpoint
PET studies in cancer ... Iressa a quinazoline-based small molecule, an EGFR TK inhibitor; In phase I objective responses observed in NSCLC ... Using Biomarkers and Surrogate Endpoints to Accelerate Drug ....
https://petsymposium.org/2004/talks/rump/bwaters.ppt
PETAGREE PETS
Tipo: Presentación Powerpoint
PET studies in cancer ... Iressa a quinazoline-based small molecule, an EGFR TK inhibitor; In phase I objective responses observed in NSCLC ... Using Biomarkers and Surrogate Endpoints to Accelerate Drug ....
http://petagreepets.com/PETAGREE/PETAGREE_PETS.ppt
Update to the City Council Transportation Committee
Tipo: Presentación Powerpoint
PET studies in cancer ... Iressa a quinazoline-based small molecule, an EGFR TK inhibitor; In phase I objective responses observed in NSCLC ... Using Biomarkers and Surrogate Endpoints to Accelerate Drug ....
https://www.honolulu.gov/rep/site/dts/bike_docs/King_Street_NB_November_2014.ppt
Using Biomarkers and Surrogate Endpoints to Accelerate Drug ...
Tipo: Presentación Powerpoint
PET studies in cancer ... Iressa a quinazoline-based small molecule, an EGFR TK inhibitor; In phase I objective responses observed in NSCLC ... Using Biomarkers and Surrogate Endpoints to Accelerate Drug ....
https://ww2.amstat.org/meetings/fdaworkshop/presentations/2006/Gracie%20Lieberman%20Biomarkers%20and%20Surrogate%20Endpoints.ppt
Libro en otros formatos: